Waters opens new solution centre in Singapore
Is equipped with advanced analytical application development and demonstration capabilities and training facilitie
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
TB Diagnostic beyond culture
TB Diagnosis continues to remain the Achilles heel in the eradication of the disease even as efforts step up worldwide to develop…
The TB Armamentarium
With riding incidence of TB, Domestic and MNC pharma are trying to dominate the anti-TB market. As a result, around 15 new drugs…
Union Budget 2013 – Dashed hopes
Like last year, this year’s budget too has disappointed the Indian pharmaceutical sector. The industry feels that it did not get…
’Any business model for TB can be successful only if it can be deployed till the very bottom…
Even as the Xpert test approved by WHO is all set to revolutionise TB diagnosis, Bangalore- based Molbio Diagnostics, a JV between…
Pharmexcil urges DCGI to form committee for issues on EU Directives
DCGI likely to act on the basis of the committee's comment
HSI/India lauds DCGIs direction to eliminate animal tests for cosmetics
Marks the beginning of the end of acute oral toxicity and oral mucosal irritation animal testing for cosmetic purposes in India
M&A activity in pharma sector shifts focus to emerging markets and generics
February 2013 registers decrease in both volume and value terms
Strides Arcolab to sell Agila Specialties division to Mylan
To sell it for an aggregate sum of $1,600 million in cash and potential additional consideration of up to $250 million